High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease. [electronic resource]
Producer: 20150511Description: 356-62 p. digitalISSN:- 1468-201X
- Aged
- Atorvastatin
- Cholesterol, LDL -- blood
- Dose-Response Relationship, Drug
- Female
- Heptanoic Acids -- administration & dosage
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Incidence
- Male
- Middle Aged
- Myocardial Infarction -- epidemiology
- Myocardial Revascularization -- statistics & numerical data
- Netherlands -- epidemiology
- Peripheral Arterial Disease -- epidemiology
- Prospective Studies
- Pyrroles -- administration & dosage
- Scandinavian and Nordic Countries -- epidemiology
- Simvastatin -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.